Berry Genomics Co.,Ltd (SHE:000710)

China flag China · Delayed Price · Currency is CNY
9.92
+0.17 (1.74%)
Apr 29, 2026, 3:04 PM CST
-15.86%
Market Cap 3.51B
Revenue (ttm) 929.82M
Net Income (ttm) -196.84M
Shares Out 353.52M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,672,600
Average Volume 8,231,181
Open 9.65
Previous Close 9.75
Day's Range 9.65 - 10.02
52-Week Range 9.42 - 17.37
Beta 0.66
RSI 41.65
Earnings Date Apr 29, 2026

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a... [Read more]

Sector Healthcare
Founded 2010
Employees 1,402
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000710
Full Company Profile

Financial Performance

In 2025, Berry Genomics Co.,Ltd's revenue was 929.82 million, a decrease of -13.76% compared to the previous year's 1.08 billion. Losses were -196.84 million, 2.29% more than in 2024.

Financial Statements

News

There is no news available yet.